logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Anemia Irondeficiency

    FiltersReset Filters
    10 results

    • deferasirox

      (Deferasirox)
      Teva Pharmaceuticals Inc
      Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.

    • deferasirox

      (deferasirox)
      Bionpharma Inc.
      Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.

    • deferasirox

      (Deferasirox)
      Ascend Laboratories, LLC
      Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.

    • deferasirox

      (Deferasirox)
      Actavis Pharma, Inc.
      Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.

    • deferasirox oral granules

      (deferasirox)
      EPIC PHARMA, LLC
      Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.

    • deferasorox

      (Deferasirox)
      MSN LABORATORIES PRIVATE LIMITED
      Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.

    • deferasorox

      (Deferasirox)
      Novadoz Pharmaceuticals LLC
      Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.

    • ferric citrate

      (Ferric Citrate)
      Mylan Pharmaceuticals Inc.
      Usage: Ferric citrate tablets are indicated for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis, and for treating iron deficiency anemia in adults with chronic kidney disease not on dialysis.

    • ferrlecit

      (sodium ferric gluconate complex)
      sanofi-aventis U.S. LLC
      Usage: Ferrlecit is indicated for treating iron deficiency anemia in adults and pediatric patients aged 6 and older with chronic kidney disease on hemodialysis who are receiving supplemental epoetin therapy.

    • sodium ferric gluconate complex in sucrose

      (Sodium Ferric Gluconate Complex in Sucrose)
      Hikma Pharmaceuticals USA Inc.
      Usage: Sodium ferric gluconate complex in sucrose injection is indicated for treating iron deficiency anemia in adults and pediatric patients aged 6 years and older with chronic kidney disease on hemodialysis receiving supplemental epoetin therapy.